Share price of Sun Pharmaceutical Industries rose 4 percent in the early trade Thursday as it has received an establishment inspection report from USFDA for its Dadra formulation facility.
EIR indicates closure of plant inspection by the US regulatory agency.
"We have received a communication from the USFDA releasing a copy of the establishment inspection report in respect of the above inspection based upon our responses to the said observation letter," said company.
USFDA had inspected the plant in April 2017 as regulatory authority issued Form-483.
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
No comments:
Post a Comment